How Eli Lilly Became a $1 Trillion Company
Mounjaro and Zepbound turned Eli Lilly into a trillion-dollar pharmaceutical giant. But every blockbuster drug eventually faces competition. Here’s what Lilly is doing to stay
Mounjaro and Zepbound turned Eli Lilly into a trillion-dollar pharmaceutical giant. But every blockbuster drug eventually faces competition. Here’s what Lilly is doing to stay on top.
How Eli Lilly Got Huge By Making Us Thin Dave Ricks steered the 150-year-old drug giant to a $1 trillion market cap. Can he defeat pharma’s boom and bust cycle?
Like this video? Subscribe and turn on notifications so you don't miss any videos from Bloomberg Markets & Finance Visit for business news & analysis,
up-to-the-minute market data, features, profiles and more.
The BriefWire